The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.

Bissonnette, R; Maari, C; Forman, S; Bhatia, N; Lee, M; Fowler, J; Tyring, S; Pariser, D; Sofen, H; Dhawan, S; Zook, M; Zammit, D J; Usansky, H; Denis, L; Rao, N; Song, T; Pavel, A B; Guttman-Yassky, E

Bissonnette, R; Maari, C; Forman, S; Bhatia, N; Lee, M; Fowler, J; Tyring, S; Pariser, D; Sofen, H; Dhawan, S; Zook, M; Zammit, D J; Usansky, H; Denis, L; Rao, N; Song, T; Pavel, A B; Guttman-Yassky, E.

Affiliation

Bissonnette R; Innovaderm Research Inc., 1851 Sherbrooke Street East, Suite 502, Montreal, H2K 4L5, Quebec, Canada.
Maari C; Innovaderm Research Inc., 1851 Sherbrooke Street East, Suite 502, Montreal, H2K 4L5, Quebec, Canada.
Forman S; Forward Clinical Trials, Inc., 4915 Ehrlich Road, Tampa, 33624, FL, U.S.A.
Bhatia N; Therapeutics Clinical Research, 9025 Balboa Avenue, Suite 105, San Diego, 92123, CA, U.S.A.
Lee M; Progressive Clinical Research, P.A., LLC, 1973 North West Loop 410, Suite 106, San Antonio, 78213, TX, U.S.A.
Fowler J; Dermatology Specialists Research, 3810 Springhurst Boulevard, Suite 130, Louisville, 40241, KY, U.S.A.
Tyring S; Center for Clinical Studies, University of Texas Health Science Center, 451 North Texas Avenue, Houston, 77598, TX, U.S.A.
Pariser D; Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, 23502, VA, U.S.A.
Sofen H; Dermatology Research Associates, 8930 South Sepulveda Boulevard, Los Angeles, 90045, CA, U.S.A.
Dhawan S; Center for Dermatology Clinical Research Inc., 2557 Mowry Avenue, Suite 21 and 25, Fremont, 94538, CA, U.S.A.
Zook M; Olympian Clinical Research, 1201 South Myrtle Avenue, Clearwater, 33756, FL, U.S.A.
Zammit DJ; Asana BioSciences, LLC, 997 Lenox Drive, Suite 220, Princeton Pike Corporate Center, Lawrenceville, 08648, NJ, U.S.A.
Usansky H; Asana BioSciences, LLC, 997 Lenox Drive, Suite 220, Princeton Pike Corporate Center, Lawrenceville, 08648, NJ, U.S.A.
Denis L; Asana BioSciences, LLC, 997 Lenox Drive, Suite 220, Princeton Pike Corporate Center, Lawrenceville, 08648, NJ, U.S.A.
Rao N; Asana BioSciences, LLC, 997 Lenox Drive, Suite 220, Princeton Pike Corporate Center, Lawrenceville, 08648, NJ, U.S.A.
Song T; Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 13-76, New York, 10029, NY, U.S.A.
Pavel AB; Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 13-76, New York, 10029, NY, U.S.A.
Guttman-Yassky E; Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 13-76, New York, 10029, NY, U.S.A.

Br J Dermatol ; 181(4): 733-742, 2019 10.

Article de En | MEDLINE | ID: mdl-30919407

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Acétonitriles / Pipéridines / Pyridazines / Eczéma atopique / Inhibiteurs des Janus kinases Type d'étude: Clinical_trials / Diagnostic_studies / Risk_factors_studies Langue: En Journal: Br J Dermatol Année: 2019 Type de document: Article Pays d'affiliation: Canada Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google